Researched and written by Keith Bishop, Clinical Nutritionist, Cancer Coach, Retired Pharmacist, and Founder of Prevail Over Cancer and the Prevail Protocol.
Why Fungi Are Being Found in Human Tumors
Large sequencing studies have confirmed that low-abundance fungal DNA and fungal cells appear across multiple cancer types — including breast, lung, GI, melanoma, and gynecologic tumors. These findings do not indicate infection and do not establish fungi as carcinogens. Instead, they highlight fungi as ecological participants within the tumor microenvironment.
Clinical framing:
Fungi appear to be context-dependent modulators of the tumor microenvironment, shaped by the host’s metabolic, inflammatory, and immunologic terrain.
Terrain Conditions That Promote Fungal Persistence
Terrain Conditions That Reduce Fungal Advantage
Immune Modulation
Fungal signatures correlate with tumor-associated macrophage phenotypes, neutrophil infiltration, and dendritic cell activation.
Metabolic Crosstalk
Fungi metabolize glucose and lipids, producing byproducts that may affect:
Microbiome Interactions
Fungi co-localize with bacteria in structured tumor micro‑niches, influencing:
Beyond Cancer: Other Health Concerns Linked to Fungal Imbalance
Fungal imbalance (not infection) is associated with:
Metabolic Dysfunction
GI Dysbiosis & Barrier Integrity
Immune Dysregulation
Respiratory & Sinus Ecology
Skin & Mucosal Terrain
Fungi thrive in high-glucose environments.
Terrain‑supportive strategies include:
Polyphenols support microbial balance and immune modulation.
Examples:
Supports microbial competition and SCFA production.
Sources:
Supports insulin sensitivity and metabolic flexibility.
Improves glucose disposal and reduces inflammatory load.
Chronic cortisol elevation alters immune balance and fungal ecology.
Supportive practices include:
Expanded Supplement & Botanical Categories
These botanicals demonstrate in vitro antifungal activity and may support microbial balance as part of a terrain-focused lifestyle.
Clove (Syzygium aromaticum)
Clove and its primary compound eugenol exhibit broad antifungal activity, including effects on:
Studies show eugenol inhibits Candida species and disrupts fungal enzyme systems.⁴⁵
Garlic (Allium sativum)
Garlic contains allicin, which demonstrates antifungal activity through:
Multiple studies confirm garlic’s activity against Candida and other fungi.⁶⁷
Oregano (Origanum vulgare)
Rich in carvacrol and thymol, oregano oil shows:
Thyme (Thymus vulgaris)
Thymol and carvacrol exhibit synergistic antifungal effects, particularly against Candida species.
Cinnamon (Cinnamomum spp.)
Cinnamaldehyde demonstrates:
Tea Tree (Melaleuca alternifolia)
Terpinen‑4‑ol shows broad antifungal activity in vitro.
Berberine‑Containing Herbs
(Goldenseal, barberry, Oregon grape)
Berberine demonstrates:
Check out OncoAdjunct Pathway #3.
Support antioxidant capacity and immune balance.
Designs for Health Supplements
Designs for Health Supplements
Fungal Terrain and Cancer Summary
The emerging literature suggests:
Educational Use Disclaimer
This guide is for educational and informational purposes only. It is not intended to provide medical advice, diagnose conditions, or replace individualized guidance from a licensed healthcare professional. Patients should always consult their medical team before making changes to their diet, lifestyle, supplements, or treatment plan. Statements regarding dietary supplements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease.
Fungal Terrain and Cancer Reference Sources
Narunsky‑Haziza L, Sepich‑Poore GD, Livyatan I, et al.
Pan‑cancer analyses reveal cancer‑type‑specific fungal ecologies and bacteriome interactions. Cell. 2022;185(20):3789‑3806. doi:10.1016/j.cell.2022.09.005. https://pubmed.ncbi.nlm.nih.gov/36179670/
Dohlman AB, Klug J, Mesko M, et al. A pan‑cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors. Cell. 2022;185(20):3807‑3822.e12. doi:10.1016/j.cell.2022.09.015. https://pubmed.ncbi.nlm.nih.gov/36179671/
Ding T, Liu C, Li Z. The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications. Mol Cancer. 2025;24(1):1‑15. doi:10.1186/s12943‑025‑02227‑8.
https://pubmed.ncbi.nlm.nih.gov/39815314/
Marchese A, Barbieri R, Coppo E, et al. Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint. Crit Rev Microbiol. 2017;43(6):668-689. doi:10.1080/1040841X.2017.1295225 https://pubmed.ncbi.nlm.nih.gov/28346030/
Pinto E, Vale‑Silva L, Cavaleiro C, Salgueiro L. Antifungal activity of clove essential oil (Eugenia caryophyllata) on Candida, Aspergillus and dermatophyte species.
J Med Microbiol. 2009;58(11):1454‑1462. doi:10.1099/jmm.0.010538‑0.
https://pubmed.ncbi.nlm.nih.gov/19589904/
Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect. 1999;1(2):125‑129. doi:10.1016/S1286‑4579(99)80003‑3.
https://pubmed.ncbi.nlm.nih.gov/10594976/
Davis SR. An overview of the antifungal properties of allicin and its potential therapeutic applications. J Nutr. 2006;136(3 Suppl):716S‑725S. doi:10.1093/jn/136.3.716S.
https://pubmed.ncbi.nlm.nih.gov/16484550/
Xu Lou, I., Zhou, H., & Wan, H. (2025). The critical role of Th17 cells and IL-17A in autoimmune and inflammation-associated neurological diseases: Mechanisms and therapeutic perspectives. Frontiers in Immunology, 16, 1656422. https://doi.org/10.3389/fimmu.2025.1656422